Iape-targeted active immunotherapy

Iape-targeted active immunotherapy has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 30, 2026: “Immunotherapy improved blood sugar control in diabetic mice”.

Intervention

1 paper studies it4 findingsUpdated Oct 29, 2026

1 new paper in 30 daysSee all 1

None of its findings points the other way.

1 lab in 1 country

Animals1

What did studies of Iape-targeted active immunotherapy find?

Studies of Iape-targeted active immunotherapy measured 4 outcomes; the most studied are pancreatic islet senescence markers (1 study), steatosis-associated histomorphometric features (1) and glucose homeostasis (1).

Pancreatic islet senescence markers

downin mice1

1 study

Iape-targeted active immunotherapy decreases pancreatic islet senescence markers in mice (DS-HFD mouse model of accelerated diabetes).
“They furthermore showed reduction in histomorphometry features consistent with steatosis, hepatocyte binucleation, reduced adipocyte size, and pancreatic islet senescence markers p16INK4a and p21Cip1/waf1”
AnimalsDS-HFD mouse model of accelerated diabetespancreatic islet
Immunotherapy improved blood sugar control in diabetic mice
Molecular metabolismOct 29, 2026

More on Pancreatic islet senescence markers

Steatosis-associated histomorphometric features

downin mice1

1 study

Iape-targeted active immunotherapy decreases steatosis-associated histomorphometric features in mice (DS-HFD mouse model of accelerated diabetes).
“They furthermore showed reduction in histomorphometry features consistent with steatosis, hepatocyte binucleation, reduced adipocyte size, and pancreatic islet senescence markers p16INK4a and p21Cip1/waf1”
AnimalsDS-HFD mouse model of accelerated diabetesliver
Immunotherapy improved blood sugar control in diabetic mice
Molecular metabolismOct 29, 2026

Glucose homeostasis

upin mice1

1 study

Iape-targeted active immunotherapy improves glucose homeostasis in mice (DS-HFD mouse model of accelerated diabetes).
“In Vivo, DS-HFD + IAPE-Tx mice showed reduced weight gain, improved fasting insulin-glucose homeostasis and oral glucose tolerance.”
AnimalsDS-HFD mouse model of accelerated diabetes
Immunotherapy improved blood sugar control in diabetic mice
Molecular metabolismOct 29, 2026

Weight gain

downin mice1

1 study

Iape-targeted active immunotherapy decreases weight gain in mice (DS-HFD mouse model of accelerated diabetes).
“In Vivo, DS-HFD + IAPE-Tx mice showed reduced weight gain, improved fasting insulin-glucose homeostasis and oral glucose tolerance.”
AnimalsDS-HFD mouse model of accelerated diabetes
Immunotherapy improved blood sugar control in diabetic mice
Molecular metabolismOct 29, 2026

Latest

1 paper in 12 months

Molecular MetabolismOct 30

Immunotherapy improved blood sugar control in diabetic mice

An immunization experiment in mice modeling accelerated diabetes reduced weight gain and improved glucose tolerance, but how it worked remained unclear.An immunization experiment in mice modeling accelerated diabetes reduced weight gain and improved glucose tolerance, but how it worked remained unclear.

Mouse studyInterventions

Paper

Iape-targeted active immunotherapy

What did studies of Iape-targeted active immunotherapy find?

Latest

Immunotherapy improved blood sugar control in diabetic mice

Related